Kyung Eun Kim Selected Research

Kyung Eun Kim Research Topics

Disease

16	Inflammation (Inflammations) 01/2022 - 03/2009
14	Neoplasms (Cancer) 10/2021 - 06/2009
11	Obesity 05/2022 - 09/2014
8	Insulin Resistance 05/2022 - 09/2015
6	Neuroinflammatory Diseases 11/2021 - 10/2017
6	Melanoma (Melanoma, Malignant) 10/2021 - 12/2010
4	Fibrosis (Cirrhosis) 01/2020 - 10/2009
4	Infections 04/2019 - 06/2006
3	Skin Diseases (Skin Disease) 04/2020 - 05/2016
3	Neoplasm Metastasis (Metastasis) 12/2010 - 06/2009
2	Non-alcoholic Fatty Liver Disease 05/2022 - 01/2016
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2020
2	Cognitive Dysfunction 11/2021 - 02/2020
2	Memory Disorders (Memory Loss) 10/2021 - 02/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2020 - 01/2020
2	Experimental Arthritis 01/2020 - 11/2016
2	Weight Gain 01/2019 - 09/2015
2	Body Weight (Weight, Body) 01/2018 - 01/2016
2	Skin Neoplasms (Skin Cancer) 12/2016 - 05/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2016 - 02/2016
2	Sepsis (Septicemia) 01/2016 - 04/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015 - 09/2014
2	Vascular Remodeling 03/2007 - 06/2006
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2022
1	Type 2 Diabetes Mellitus (MODY) 05/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Brain Injuries (Brain Injury) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2021
1	Muscular Atrophy (Muscle Atrophy) 05/2021
1	Sarcopenia 05/2021
1	Seizures (Absence Seizure) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2020
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020
1	Acne Vulgaris 01/2020
1	Cardiomegaly (Heart Hypertrophy) 01/2020
1	Iron Overload 01/2020
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018
1	Diabetes Mellitus 10/2017
1	Hyperglycemia 10/2017

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2010
9	Lipocalin-2IBA 05/2022 - 01/2016
6	CytokinesIBA 10/2021 - 02/2016
5	LeptinIBA 05/2022 - 01/2018
5	Therapeutic UsesIBA 01/2018 - 01/2016
4	IronIBA 05/2021 - 01/2020
4	Sirtuin 1IBA 01/2019 - 09/2014
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2010
3	CollagenIBA 01/2020 - 03/2016
3	Messenger RNA (mRNA)IBA 11/2019 - 02/2016
2	NFATC Transcription FactorsIBA 11/2021 - 10/2017
2	RNA (Ribonucleic Acid)IBA 05/2021 - 09/2020
2	Streptozocin (Streptozotocin)FDA Link 02/2020 - 10/2017
2	Biological ProductsIBA 01/2020 - 09/2016
2	Interleukin-18 (Interleukin 18)IBA 11/2019 - 11/2016
2	InterleukinsIBA 12/2016 - 10/2016
2	Angiopoietin-2IBA 01/2016 - 11/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 09/2015
2	AngiopoietinsIBA 08/2010 - 03/2007
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Amyloid beta-PeptidesIBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 10/2021
1	Iron-Binding ProteinsIBA 05/2021
1	Kainic Acid (Kainate)IBA 01/2021
1	Dynamins (Dynamin)IBA 01/2021
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 09/2020
1	deoxyuridine triphosphateIBA 09/2020
1	Inositol (Myoinositol)IBA 09/2020
1	Lysosomal-Associated Membrane Protein 1IBA 09/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2020
1	Exenatide (Byetta)FDA Link 02/2020
1	Neuroprotective AgentsIBA 02/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 02/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 02/2020
1	Calcium-Binding ProteinsIBA 02/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Heme Oxygenase-1IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	AdipokinesIBA 09/2019
1	Complement C1 (Complement 1)IBA 04/2019
1	Carrier Proteins (Binding Protein)IBA 04/2019
1	NeurograninIBA 01/2019
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2018
1	nilotinib FDA Link 01/2018
1	lobeglitazoneIBA 01/2018
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	4- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- trifluoromethylphenyl)- 3- (4- pyrazin- 2- ylpyrimidin- 2- ylamino)benzamideIBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	PPAR gammaIBA 01/2018
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2018

Therapy/Procedure

4	Caloric Restriction 09/2020 - 01/2016
3	Therapeutics 04/2020 - 12/2012
2	Drug Therapy (Chemotherapy) 01/2016 - 12/2010
1	Photochemotherapy (Photodynamic Therapy) 04/2020
1	Intraperitoneal Injections 10/2017